Literature DB >> 33349902

Isolation, Culture, Cryopreservation, and Preparation of Umbilical Cord-Derived Mesenchymal Stem Cells as a Final Cellular Product Under Good Manufacturing Practices-Compliant Conditions.

Nurullah Aydoğdu1, Olga Nehir Öztel1, Erdal Karaöz2,3,4.   

Abstract

Mesenchymal stem cells have gained popularity in cell-based therapies due to their regenerative capabilities, immunomodulation properties, and paracrine activity through trophic factors. It is of utmost importance to establish clinical-grade procedures for the preparation of the mesenchymal stem cells for clinical applications. Here, we describe detailed procedures for isolation, culture, cryopreservation, and preparation of mesenchymal stem cells derived from umbilical cord as a final product under good manufacturing practices-compliant conditions.

Keywords:  Cell isolation; Cell therapy; Culture; GMP; Stem cells; Umbilical cord

Year:  2021        PMID: 33349902     DOI: 10.1007/7651_2020_332

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

1.  Cell therapy: cGMP facilities and manufacturing.

Authors:  Raffaella Giancola; Tiziana Bonfini; Antonio Iacone
Journal:  Muscles Ligaments Tendons J       Date:  2012-10-16

Review 2.  Trophic Effects of Mesenchymal Stem Cells in Tissue Regeneration.

Authors:  Yao Fu; Lisanne Karbaat; Ling Wu; Jeroen Leijten; Sanne K Both; Marcel Karperien
Journal:  Tissue Eng Part B Rev       Date:  2017-12       Impact factor: 6.389

Review 3.  Development of a cell-based medicinal product: regulatory structures in the European Union.

Authors:  Patricia Gálvez; Beatriz Clares; Abdelkrim Hmadcha; Adolfina Ruiz; Bernat Soria
Journal:  Br Med Bull       Date:  2012-11-25       Impact factor: 4.291

Review 4.  Mesenchymal stem cell treatment for autoimmune diseases: a critical review.

Authors:  Fernando E Figueroa; Flavio Carrión; Sandra Villanueva; Maroun Khoury
Journal:  Biol Res       Date:  2012       Impact factor: 5.612

Review 5.  Cell-based product classification procedure: What can be done differently to improve decisions on borderline products?

Authors:  Ander Izeta; Concha Herrera; Rosario Mata; Giuseppe Astori; Rosaria Giordano; Carmen Hernández; Laura Leyva; Salvador Arias; Salvador Oyonarte; Gloria Carmona; Natividad Cuende
Journal:  Cytotherapy       Date:  2016-05-18       Impact factor: 5.414

6.  Multilineage potential of adult human mesenchymal stem cells.

Authors:  M F Pittenger; A M Mackay; S C Beck; R K Jaiswal; R Douglas; J D Mosca; M A Moorman; D W Simonetti; S Craig; D R Marshak
Journal:  Science       Date:  1999-04-02       Impact factor: 47.728

7.  Establishing a stem cell culture laboratory for clinical trials.

Authors:  Elíseo Joji Sekiya; Andresa Forte; Telma Ingrid Borges de Bellis Kühn; Felipe Janz; Sérgio Paulo Bydlowski; Adelson Alves
Journal:  Rev Bras Hematol Hemoter       Date:  2012

8.  From skin biopsy to neurons through a pluripotent intermediate under Good Manufacturing Practice protocols.

Authors:  Saravanan Karumbayaram; Peiyee Lee; Soheila F Azghadi; Aaron R Cooper; Michaela Patterson; Donald B Kohn; April Pyle; Amander Clark; James Byrne; Jerome A Zack; Kathrin Plath; William E Lowry
Journal:  Stem Cells Transl Med       Date:  2011-12-07       Impact factor: 6.940

Review 9.  Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs.

Authors:  Andreas Robert Rudolf Weiss; Marc Hendrik Dahlke
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 7.561

Review 10.  Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine.

Authors:  Matthew B Murphy; Kathryn Moncivais; Arnold I Caplan
Journal:  Exp Mol Med       Date:  2013-11-15       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.